8/103 sources · 3 publishersUpdated Oct 9, 22:14 UTC
Integra LifeSciences issues $450 million of 9.5% senior secured notes due 2033
Integra LifeSciences announced the pricing of a $450 million senior secured note offering carrying a 9.5% coupon and maturing in 2033. The transaction is slated to close on October 19, 2026. The company said the net proceeds will be used to refinance its existing credit facilities, settle related issuance costs and fund borrowings under a new credit facility.
Why it matters
The refinancing reduces the company’s reliance on older debt and may improve its credit profile, according to the company’s statement. Investors should note that the new notes increase long‑term debt on the balance sheet, which could affect leverage ratios.
Key facts
- 1Integra LifeSciences priced $450 million of senior secured notes. tradingview.com
- 2The notes bear a 9.5% interest rate. tradingview.com
- 3Maturity is set for 2033. tradingview.com
- 4Closing is expected by October 19, 2026. tradingview.com
- 5Proceeds will refinance existing credit facilities, cover issuance fees and support borrowings under a new credit facility. tradingview.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.